You are required to be logged in to access the full website
Click here if you have forgotten your username or password
30 January 2023 - Biopharmaceutical company Xeris Biopharma Holdings Inc (Nasdaq: XERS) announced on Monday that the US Food and Drug Administration (FDA) has granted its subsidiary Xeris Pharmaceuticals Inc orphan-drug exclusivity for Recorlev (levo...
30 January 2023 - Drug discovery company Charles River Laboratories International Inc (NYSE: CRL) disclosed on Monday that it has acquired the remaining 80% ownership stake in SAMDI Tech Inc, a provider of screening (HTS) solutions for drug discovery...
30 January 2023 - Alpha Biopharma, a China-based developer of innovative drugs, announced on Sunday that the company's New Drug Application (NDA) for Zorifertinib, a next-generation EGFR-TKI, has been accepted by the Centre for Drug Evaluation (...
30 January 2023 - Asep Medical Holdings Inc. (CSE: ASEP) (OTCQB: SEPSF), a Canada-based company dedicated to addressing antibiotic failure by developing novel solutions for significant unmet medical needs, announced on Friday that it entered into a j...
30 January 2023 - InDex Pharmaceuticals Holding AB (publ), a Sweden-based pharmaceutical development company focusing on immunological diseases where there is a high unmet medical need for new treatment options, announced on Friday an update in the t...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe